BMC Surgery | |
The role of atherectomy in the treatment of lower extremity peripheral artery disease | |
Research Article | |
Anna Franzone1  Savio Saviano1  Cinzia Perrino1  Marco Ferrone1  Bruno Trimarco1  Andreina Carbone1  Fernando Scudiero1  Raffaele Izzo1  Giovanni Esposito1  Federica Serino1  Raffaele Piccolo1  Giuseppe Carotenuto1  Laura Scudiero1  Bruno Amato2  | |
[1] Department of Clinical Medicine, Cardiovascular and Immunological Sciences, Federico II University, Via S. Pansini 5, 80131, Naples, Italy;Department of General, Geriatric, Oncologic Surgery and Advanced Technologies, Federico II University, Via S. Pansini 5, 80131, Naples, Italy; | |
关键词: Peripheral Artery Disease; Cilostazol; Superficial Femoral Artery; Critical Limb Ischemia; Chronic Total Occlusion; | |
DOI : 10.1186/1471-2482-12-S1-S13 | |
来源: Springer | |
【 摘 要 】
BackgroundThe incidence of lower extremity peripheral artery disease (LE-PAD) continues to increase and associated morbidity remains high. Despite the significant development of percutaneous revascularization strategies, over the past decade, LE-PAD still represents a unique challenge for interventional cardiologists and vascular surgeons.MethodTypical features of atherosclerosis that affects peripheral vascular bed (diffuse nature, poor distal runoff, critical limb ischemia, chronic total occlusion) contribute to the disappointing results of traditional percutaneous transluminal angioplasty (PTA). New technologies have been developed in attempt to improve the safety and effectiveness of percutaneous revascularization. Among these, atherectomy, debulking and removing atherosclerotic plaque, offers the potential advantage of eliminating stretch on arterial walls and reducing rates of restenosis.ConclusionsThis review summarizes the features and the current applications of new debulking devices.
【 授权许可】
Unknown
© Franzone et al; licensee BioMed Central Ltd. 2012. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202311094558668ZK.pdf | 373KB | download |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]
- [39]
- [40]
- [41]
- [42]
- [43]
- [44]
- [45]
- [46]
- [47]
- [48]
- [49]
- [50]
- [51]
- [52]
- [53]
- [54]
- [55]
- [56]